International Society for the Study of Women's Sexual Health

DYSPAREUNIA: CMS CLARIFICATION RESULTS IN EXPANDED TREATMENT AND COVERAGE UNDER MEDICARE PART D

ISSWSH is pleased to announce and recognize the Centers for Medicare and Medicaid Services (CMS) clarification of the statutory intent of “Prescription Drug Benefits” section 1860D-2(e)(2)(A) of the Social Security Act, stating that drugs for the treatment of moderate to severe dyspareunia (pain during sexual intercourse) due to menopause, are not excluded from Medicare Part D coverage when used consistent with this labeling.

 

ISSWSH, alongside the North American Menopause Society (NAMS), the American College of Obstetricians and Gynecologists (ACOG), and many other interested parties are committed to women’s health and particularly sexual health. James A. Simon, MD, President of ISSWSH, thanks these partners and commends CMS for this clarification that now allows women suffering from dyspareunia, to access expanded treatment options and get coverage under Medicare Part D.

View Press Release

Save the Date

ISSWSH Fall Course 2019
November 14-16, 2019   171 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2020
March 5-8, 2020   283 days left
Renaissance Orlando at Seaworld, Orlando, FL, USA

Latest Tweets

The Female Sexual Function Index (FSFI)— A Systematic Review of Measurement Properties https://t.co/QYYUWdqWmg ISSWSH
Get your "Textbook of Female Sexual Function and Dysfunction: Diagnosis and Treatment" here: https://t.co/mhbyVVf12M ISSWSH
Not much literature exists on highly sexual women.  Why? Could studying women w/higher sexual drives help us unders… https://t.co/scl0E4oHl8 ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!